108 related articles for article (PubMed ID: 30333301)
1. Injury promotes sarcoma development in a genetically and temporally restricted manner.
Van Mater D; Xu E; Reddy A; Añó L; Sachdeva M; Huang W; Williams N; Ma Y; Love C; Happ L; Dave S; Kirsch DG
JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333301
[TBL] [Abstract][Full Text] [Related]
2. Methods to generate genetically engineered mouse models of soft tissue sarcoma.
Dodd RD; Añó L; Blum JM; Li Z; Van Mater D; Kirsch DG
Methods Mol Biol; 2015; 1267():283-95. PubMed ID: 25636474
[TBL] [Abstract][Full Text] [Related]
3. The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
Hildebrand KM; Singla AK; McNeil R; Marritt KL; Hildebrand KN; Zemp F; Rajwani J; Itani D; Bose P; Mahoney DJ; Jirik FR; Monument MJ
PLoS One; 2021; 16(7):e0253864. PubMed ID: 34242269
[TBL] [Abstract][Full Text] [Related]
4. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
5. Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele.
Wu J; Liu X; Nayak SG; Pitarresi JR; Cuitiño MC; Yu L; Hildreth BE; Thies KA; Schilling DJ; Fernandez SA; Leone G; Ostrowski MC
PLoS One; 2017; 12(9):e0184984. PubMed ID: 28934293
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis.
Young NP; Crowley D; Jacks T
Cancer Res; 2011 Jun; 71(11):4040-7. PubMed ID: 21512139
[TBL] [Abstract][Full Text] [Related]
7. Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma.
Lee CL; Mowery YM; Daniel AR; Zhang D; Sibley AB; Delaney JR; Wisdom AJ; Qin X; Wang X; Caraballo I; Gresham J; Luo L; Van Mater D; Owzar K; Kirsch DG
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31112524
[TBL] [Abstract][Full Text] [Related]
8. A spatially and temporally restricted mouse model of soft tissue sarcoma.
Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
[TBL] [Abstract][Full Text] [Related]
9. Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice.
Lee CL; Moding EJ; Huang X; Li Y; Woodlief LZ; Rodrigues RC; Ma Y; Kirsch DG
Dis Model Mech; 2012 May; 5(3):397-402. PubMed ID: 22228755
[TBL] [Abstract][Full Text] [Related]
10. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
11. Progression of Chronic Pancreatitis to Pancreatic Cancer: Is There a Role of Gene Mutations as a Screening Tool?
Rashid S; Singh N; Gupta S; Rashid S; Nalika N; Sachdev V; Bal CS; Datta Gupta S; Chauhan SS; Saraya A
Pancreas; 2018 Feb; 47(2):227-232. PubMed ID: 29303908
[TBL] [Abstract][Full Text] [Related]
12. p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma.
Doyle B; Morton JP; Delaney DW; Ridgway RA; Wilkins JA; Sansom OJ
J Pathol; 2010 Oct; 222(2):129-37. PubMed ID: 20662002
[TBL] [Abstract][Full Text] [Related]
13. Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway.
Van Mater D; Añó L; Blum JM; Webster MT; Huang W; Williams N; Ma Y; Cardona DM; Fan CM; Kirsch DG
Cancer Res; 2015 Feb; 75(3):605-14. PubMed ID: 25503558
[TBL] [Abstract][Full Text] [Related]
14. KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.
Tang FH; Hsieh TH; Hsu CY; Lin HY; Long CY; Cheng KH; Tsai EM
Int J Cancer; 2017 Apr; 140(8):1860-1869. PubMed ID: 28032649
[TBL] [Abstract][Full Text] [Related]
15. Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer.
Weyandt JD; Lampson BL; Tang S; Mastrodomenico M; Cardona DM; Counter CM
PLoS One; 2015; 10(10):e0140253. PubMed ID: 26452271
[TBL] [Abstract][Full Text] [Related]
16. Zeb1 in Stromal Myofibroblasts Promotes
Sangrador I; Molero X; Campbell F; Franch-Expósito S; Rovira-Rigau M; Samper E; Domínguez-Fraile M; Fillat C; Castells A; Vaquero EC
Cancer Res; 2018 May; 78(10):2624-2637. PubMed ID: 29490942
[TBL] [Abstract][Full Text] [Related]
17. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
[TBL] [Abstract][Full Text] [Related]
18. Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner.
Muñoz DM; Tung T; Agnihotri S; Singh S; Guha A; Zadeh G; Hawkins C
Glia; 2013 Nov; 61(11):1862-72. PubMed ID: 24038521
[TBL] [Abstract][Full Text] [Related]
19. Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells.
Hettmer S; Liu J; Miller CM; Lindsay MC; Sparks CA; Guertin DA; Bronson RT; Langenau DM; Wagers AJ
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20002-7. PubMed ID: 22135462
[TBL] [Abstract][Full Text] [Related]
20. Development of transforming function during transduction of proto-ras into Harvey sarcoma virus.
Lang M; Treinies I; Duesberg PH; Kurth R; Cichutek K
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):654-8. PubMed ID: 8290577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
